Open access
Aug 2026
CX3CR1⁺ CD8⁺ cytotoxic T cells drive tumor killing in esophageal squamous cell carcinoma during neoadjuvant therapy
Multi-omics profiling of ESCC patients receiving neoadjuvant therapy is presented and a response-associated CX3CR1⁺CD8⁺ cytotoxic effector state is identified that may inform neoadjuvant ICI-based therapy in ESCC.
Ya-Hui Zhao, Ruixiang Zhang, Yang Li et al.
· Nature Communications · 0 citations